Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gynecology

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    November 2017
  1. FRENEL JS, Le Tourneau C, O'Neil B, Ott PA, et al
    Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
    J Clin Oncol. 2017 Nov 2:JCO2017745471. doi: 10.1200/JCO.2017.74.5471.
    PubMed     Text format     Abstract available


    August 2017
  2. PIGNATA S, Scambia G, Bologna A, Signoriello S, et al
    Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
    J Clin Oncol. 2017 Aug 21:JCO2017734293. doi: 10.1200/JCO.2017.73.4293.
    PubMed     Text format     Abstract available


  3. CHILDERS CP, Childers KK, Maggard-Gibbons M, Macinko J, et al
    National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
    J Clin Oncol. 2017 Aug 18:JCO2017736314. doi: 10.1200/JCO.2017.73.6314.
    PubMed     Text format     Abstract available


    April 2017
  4. KONECNY GE
    Understanding Exceptional Responses to Poly (ADP-ribose) Polymerase Inhibition in Sporadic Ovarian Cancer.
    J Clin Oncol. 2017;35:1151-1153.
    PubMed     Text format    


  5. TAYLOR JS, Rajan SS, Zhang N, Meyer LA, et al
    End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.
    J Clin Oncol. 2017 Apr 7:JCO2016702894. doi: 10.1200/JCO.2016.70.2894.
    PubMed     Text format     Abstract available


    January 2017
  6. FOTOPOULOU C, Sehouli J, Aletti G, Harter P, et al
    Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.
    J Clin Oncol. 2017 Jan 9:JCO2016710723.
    PubMed     Text format    


    December 2016
  7. COPUR MS, Gauchan D, Ramaekers R, Crockett D, et al
    Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer.
    J Clin Oncol. 2016 Dec 28:JCO2016707125.
    PubMed     Text format    


  8. SCHRAM AM, Iasonos A, Hyman DM
    Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian Cancer.
    J Clin Oncol. 2016;34:4312-4314.
    PubMed     Text format    


    September 2016
  9. MEYER LA, Cronin AM, Sun CC, Bixel K, et al
    Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.
    J Clin Oncol. 2016 Sep 6. pii: JCO681239.
    PubMed     Text format     Abstract available


    August 2016
  10. DRYDEN-PETERSON S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, et al
    HIV Infection and Survival Among Women With Cervical Cancer.
    J Clin Oncol. 2016 Aug 29. pii: JCO679613.
    PubMed     Text format     Abstract available


  11. MILESHKIN LR, Freimund AE
    Improvement of Outcomes for Women With HIV Infection and Cervical Cancer.
    J Clin Oncol. 2016 Aug 29. pii: JCO690784.
    PubMed     Text format    


    July 2016
  12. CHUANG LT, Feldman S, Nakisige C, Temin S, et al
    Management and Care of Women With Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Clin Oncol. 2016 Jul 5. pii: JCO683789.
    PubMed     Text format    


    May 2016
  13. ABDERRAHMAN B, Jordan VC
    Estrogen Deprivation Therapy in Ovarian Cancer: An Opportunity.
    J Clin Oncol. 2016 May 23. pii: JCO673137.
    PubMed     Text format    


    March 2016
  14. KILICKAP S, Tural D
    Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?
    J Clin Oncol. 2016 Mar 21. pii: JCO653683.
    PubMed     Text format    


  15. VOUTSADAKIS IA
    On Adjuvant Hormone Therapy in Epithelial Ovarian Cancer.
    J Clin Oncol. 2016 Mar 21. pii: JCO663245.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: